NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 37 filers reported holding NOVELION THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $3,000 | +200.0% | 3,823 | +129.5% | 0.00% | – |
Q2 2019 | $1,000 | -87.5% | 1,666 | -72.9% | 0.00% | – |
Q1 2019 | $8,000 | – | 6,148 | +1112.6% | 0.00% | – |
Q4 2018 | $0 | -100.0% | 507 | -92.1% | 0.00% | – |
Q3 2018 | $19,000 | +171.4% | 6,421 | +228.1% | 0.00% | – |
Q2 2018 | $7,000 | – | 1,957 | +7148.1% | 0.00% | – |
Q1 2018 | $0 | -100.0% | 27 | -96.3% | 0.00% | – |
Q4 2017 | $2,000 | -50.0% | 724 | +35.1% | 0.00% | – |
Q3 2017 | $4,000 | – | 536 | +1885.2% | 0.00% | – |
Q2 2017 | $0 | -100.0% | 27 | -96.6% | 0.00% | – |
Q1 2017 | $8,000 | -42.9% | 801 | -53.6% | 0.00% | – |
Q4 2016 | $14,000 | – | 1,726 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|